Cite
HARVARD Citation
Boddu, P. et al. (2019). Outcomes of patients with chronic phase chronic myeloid leukemia (CML-CP) after discontinuation of frontline ponatinib therapy. Leukemia & lymphoma. 60 (13), pp. 3172-3180. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Boddu, P. et al. (2019). Outcomes of patients with chronic phase chronic myeloid leukemia (CML-CP) after discontinuation of frontline ponatinib therapy. Leukemia & lymphoma. 60 (13), pp. 3172-3180. [Online].